Tubacex (TUBA)

Real-time derived


	Symbol		Exchange		Currency
	TUBA		Derived		EUR	Real-time
	TUBA		Madrid		EUR	Delayed
	TUBe		BATS Europe		EUR	Delayed
	0KD1		London		EUR	Real-time

Currency in EUR

Disclaimer

3.440

+0.045(+1.47%)

Closed10/10

Fair Value

Day's Range

3.370

3.495

52 wk Range

2.630

3.690

TUBA Income Statement

Featured here, the Income Statement (earnings report) for Tubacex, showing the company's financial performance from operating and non operating activities such as revenue, expenses and income for the last 4 periods (either quarterly or annually).

Advanced Income Statement

Period Ending:

2014

31/12

2015

31/12

2016

31/12

2017

31/12

2018

31/12

2019

31/12

2020

31/12

2021

31/12

2022

31/12

2023

31/12

Total Revenues

618.44

463.27

343.54

717.48

854.44

Total Revenues Growth

-1.18%

-25.09%

-25.84%

+108.85%

+19.09%

Cost Of Revenues

338.96

260.02

173.37

294.78

384.84

Gross Profit

279.48

203.25

170.17

422.69

469.59

Gross Profit Growth

-7.48%

-27.27%

-16.28%

+148.39%

+11.1%

Gross Profit Margin %

45.19%

43.87%

49.53%

58.91%

54.96%

Other Operating Expenses, Total

268.31

221.96

201.29

378.24

388.85

	Other Operating Expenses, Total Growth
	R&D Expenses
	Selling General & Admin Expenses
	Other Operating Expenses

aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	+0.08%	-17.27%	-9.31%	+87.91%	+2.81%
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-	-	-	-	-
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	150.63	132.03	104.02	145.63	159.16
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	74.77	44.92	52.74	184.71	185.21

Operating Income

11.17

-18.71

-31.12

44.45

80.74

Operating Income Growth

-67.15%

-267.5%

-66.34%

+242.85%

+81.63%

EBIT Margin %

1.81%

-4.04%

-9.06%

6.2%

9.45%

Net Interest Expenses

-12.71

-12.82

-12.66

-19.65

-31.48

Net Interest Expenses Growth

+21.12%

-0.82%

+1.2%

-55.15%

-60.24%

Interest Expense, Total

-13.5

-14.28

-14.57

-22.26

-33.16

Interest And Investment Income

0.79

1.46

1.91

2.61

1.68

Other Non Operating Expenses, Total

0.43

-1.84

0.93

2.37

0.32

EBT, Excl. Unusual Items

-1.11

-33.37

-42.86

27.17

49.58

Gain (Loss) On Sale Of Assets

-

-

-

-

-

Other Unusual Items, Total

12.99

5.34

-

-

-

EBT, Incl. Unusual Items

11.5

-27.92

-42.42

26.87

49.58

EBT, Incl. Unusual Items Growth

-42.2%

-342.75%

-51.96%

+163.33%

+84.55%

EBT, Incl. Unusual Items Margin

1.86%

-6.03%

-12.35%

3.74%

5.8%

Income Tax Expense

-3.17

-1.53

-3.49

3.85

6.76

Net Income to Company

14.67

-25.18

-35.2

23.02

42.82

Minority Interest

-3.53

-0.12

2.99

-2.79

-6.48

Net Income

11.15

-25.3

-32.21

20.23

36.33

Net Income Growth

-35.87%

-326.95%

-27.31%

+162.82%

+79.56%

Net Income Margin %

1.8%

-5.46%

-9.38%

2.82%

4.25%

Preferred Dividend and Other Adjustments

-

-

-

-

-

Net Income to Common Excl. Extra Items

11.15

-26.51

-35.95

20.23

36.33

Basic EPS - Continuing Operations

0.09

-0.21

-0.29

0.17

0.3

Basic EPS - Continuing Operations Growth

-35.76%

-341.49%

-40.49%

+157.43%

+79.46%

Diluted EPS - Continuing Operations

0.08

-0.21

-0.29

0.16

0.29

Diluted EPS - Continuing Operations Growth

-37.09%

-347.82%

-40.49%

+155.86%

+79.45%

Basic Weighted Average Shares Outstanding

129.62

127.61

123.18

120.74

120.8

Diluted Weighted Average Shares Outstanding

133.02

127.61

123.18

124.14

124.2

Dividend Per Share

-

-

-

0.06

0.12

Dividend Per Share Growth

-

-

-

-

+87.4%

EBITDA

52.53

26.54

10.2

89.14

125.08

EBITDA Growth

-24.01%

-49.47%

-61.58%

+774.25%

+40.32%

EBITDA Margin %

8.49%

5.73%

2.97%

12.42%

14.64%

EBIT